Article Details
Retrieved on: 2023-01-04 09:40:41
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
... LAG3-targeted drugs unleash the immune system on cancer cells. The FDA approved the first-in-class relatlimab in combination with BMS's ...
Article found on: www.nature.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here